HangzhouPeople’s Republic of ChinaAs iaB-Cell LymphomaCOVID-19CancerCoronavirusCyborgsDrugs and TherapiesEmerging TechnologiesHealth and MedicineHematologyImmunologyImmunoprol iferative DisordersLarge B-Cell LymphomaLymphatic Diseases and ConditionsL ymphomaLymphoproliferative DisordersMachine LearningOncologyRNA VirusesRisk and PreventionSARS-CoV-2ScreeningSevere Acute Respiratory Syndrome C oronavirus 2ViralVirology
2024